The National Institutes of Health (NIH) intends to award a sole source contract to Haemonetics Corporation for a Preventative Maintenance Agreement concerning two Automated Cell Processors ACP® 215. The contract will cover preventative maintenance services for a base year and three optional one-year periods, ensuring that the equipment operates in compliance with FDA regulations and manufacturer specifications, which is critical for supporting patient care through blood product services. Interested parties capable of providing similar services may submit a capability statement by January 27, 2025, to Emeka Onyejekwe at emeka.onyejekwe@nih.gov for consideration, although the decision to pursue competitive procurement remains at the discretion of the government.